By
Dawn Merton Boothe, DVM, PhD, Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University
Novobiocin is a narrow-spectrum antibiotic that may be bacteriostatic or bactericidal at higher concentrations. It is active mostly against gram-positive bacteria but also against a few gram-negative bacteria. There is a synergistic effect with tetracyclines. Many species of bacteria can develop resistance to novobiocin. Adverse reactions are quite frequent after administration. Its main use is in combination with other agents for treatment of bovine mastitis.
Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside of the US and Canada) is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Veterinary Manual was first published in 1955 as a service to the community. The legacy of this great resource continues in the online and mobile app versions today.
This site complies with the HONcode standard for trustworthy health information:
verify here.
